Published in Hepatitis Weekly, November 6th, 2000
The researchers conducted a follow-up study of almost 1,000 patients with HCV who had completed IFN therapy. A. Kasahara was the lead author of the study.
Two hundred and ninety-six patients demonstrated signs of short-term biochemical sustained response (i.e., six months) after completing treatment. This determination was made based on normal serum alanine aminotransferase (ALT) levels. Serum ALT values are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.